ArticleCancers2021

The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab.

Matteo Bauckneht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.